|
Lipids
Citations 371-380 of 396 total displayed.
|
Past content
(since Feb 1999):
|
- Clinical Investigations and Reports
Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
- Antonio M. Gotto, Jr, Edwin Whitney, Evan A. Stein, Deborah R. Shapiro, Michael Clearfield, Stephen Weis, Jesse Y. Jou, Alexandra Langendörfer, Polly A. Beere, Douglas J. Watson, John R. Downs, and John S. de Cani
Circulation 2000;101:477-484
[Abstract]
[Full text]
- Cardiovascular Drugs
Current Perspectives on Statins
- David J. Maron, Sergio Fazio, and MacRae F. Linton
Circulation 2000;101:207-213
[Abstract]
[Full text]
- AHA Scientific Statements
Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I
- Scott M. Grundy, Terry Bazzarre, James Cleeman, Ralph B. D’Agostino, Sr, Martha Hill, Nancy Houston-Miller, William B. Kannel, Ronald Krauss, Harlan M. Krumholz, Ronald M. Lauer, Ira S. Ockene, Richard C. Pasternak, Thomas Pearson, Paul M. Ridker, and David Wood
Circulation 2000;101:e3-11e
[Full text]
- AHA Scientific Statements
Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Tests for Silent and Inducible Ischemia : Writing Group II
- Sidney C. Smith, Jr, Ezra Amsterdam, Gary J. Balady, Robert O. Bonow, Gerald F. Fletcher, Victor Froelicher, Gregory Heath, Marian C. Limacher, Jamshid Maddahi, David Pryor, Rita F. Redberg, Edward Roccella, Thomas Ryan, Lynn Smaha, and Nanette K. Wenger
Circulation 2000;101:e12-16e
[Full text]
- AHA Scientific Statements
Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive Summary
- Sidney C. Smith, Jr, Philip Greenland, and Scott M. Grundy
Circulation 2000;101:111-116
[Full text]
- Brief Rapid Communications
Statin-Sensitive Dysregulated AT1 Receptor Function and Density in Hypercholesterolemic Men
- Georg Nickenig, Anselm T. Bäumer, Yavuz Temur, Daniela Kebben, Friedrich Jockenhövel, and Michael Böhm
Circulation 1999;100:2131-2134
[Abstract]
[Full text]
- Editorials
High-Density Lipoprotein and Plaque Regression : The Good Cholesterol Gets Even Better
- Hayes M. Dansky and Edward A. Fisher
Circulation 1999;100:1762-1763
[Full text]
- Clinical Investigations and Reports
Circulating Levels of Secretory Type II Phospholipase A2 Predict Coronary Events in Patients with Coronary Artery Disease
- Kiyotaka Kugiyama, Yasutaka Ota, Keiji Takazoe, Yasushi Moriyama, Hiroaki Kawano, Yuji Miyao, Tomohiro Sakamoto, Hirofumi Soejima, Hisao Ogawa, Hideki Doi, Seigo Sugiyama, and Hirofumi Yasue
Circulation 1999;100:1280-1284
[Abstract]
[Full text]
- AHA Science Advisory
Monounsaturated Fatty Acids and Risk of Cardiovascular Disease
- Penny M. Kris-Etherton
Circulation 1999;100:1253-1258
[Full text]
- Clinical Investigations and Reports
Purple Grape Juice Improves Endothelial Function and Reduces the Susceptibility of LDL Cholesterol to Oxidation in Patients With Coronary Artery Disease
- James H. Stein, Jon G. Keevil, Donald A. Wiebe, Susan Aeschlimann, and John D. Folts
Circulation 1999;100:1050-1055
[Abstract]
[Full text]
|
|
